Literature DB >> 7679853

Rhabdoid tumours of the central nervous system. Report of three cases with immunocytochemical and ultrastructural findings.

A Cossu1, G Massarelli, V Manetto, G Viale, F Tanda, L Bosincu, P Iuzzolino, S Cossu, R Padovani, V Eusebi.   

Abstract

Three cases of rhabdoid tumour of the central nervous system arising in a supratentorial location are reported. The patients were 18, 14, and 7 years old. All three tumours showed a common morphology. The neoplastic cells were usually globoid with round nuclei and prominent nucleoli and large acidophilic, cytoplasmic inclusions were present in many of them. These inclusions showed strong immunoreactivity for vimentin, weak immunoreactivity for epithelial membrane antigen and focal immunoreactivity for cytokeratins. Ultrastructurally they were made up of whorls of intermediate filaments, 8-10 nm in thickness. Rhabdoid tumours of the central nervous system, whatever the cell of origin, appear to be an independent entity with identifiable histology and aggressive behaviour.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7679853     DOI: 10.1007/bf01605137

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  24 in total

1.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

2.  Ultrastructure of malignant rhabdoid tumor of the kidney. A distinctive renal tumor of children.

Authors:  J E Haas; N F Palmer; A G Weinberg; J B Beckwith
Journal:  Hum Pathol       Date:  1981-07       Impact factor: 3.466

3.  Infantile sarcoma with intracytoplasmic filamentous inclusions: distinctive tumor of possible histiocytic origin.

Authors:  F Gonzalez-Crussi; R A Goldschmidt; W Hsueh; Y P Trujillo
Journal:  Cancer       Date:  1982-06-01       Impact factor: 6.860

4.  Monosomy 22 in rhabdoid or atypical tumors of the brain.

Authors:  J A Biegel; L B Rorke; R J Packer; B S Emanuel
Journal:  J Neurosurg       Date:  1990-11       Impact factor: 5.115

5.  Rhabdoid tumors of soft tissues: a clinicopathologic study of 26 cases enrolled on the Intergroup Rhabdomyosarcoma Study.

Authors:  R Kodet; W A Newton; N Sachs; A B Hamoudi; R B Raney; L Asmar; E A Gehan
Journal:  Hum Pathol       Date:  1991-07       Impact factor: 3.466

6.  Renal and extrarenal rhabdoid tumors in children: a clinicopathologic study of 14 patients.

Authors:  C Sotelo-Avila; F Gonzalez-Crussi; D deMello; C Vogler; W M Gooch; G Gale; R Pena
Journal:  Semin Diagn Pathol       Date:  1986-05       Impact factor: 3.464

7.  Paravertebral malignant rhabdoid tumor in infancy. In vitro studies of a familial tumor.

Authors:  H T Lynch; S B Shurin; B B Dahms; R J Izant; J Lynch; B S Danes
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

8.  Malignant rhabdoid tumor of the heart in an infant.

Authors:  E J Small; G J Gordon; B B Dahms
Journal:  Cancer       Date:  1985-06-15       Impact factor: 6.860

9.  Malignant rhabdoid tumour of soft tissue. An ultrastructural and immunohistological study of a pelvic tumour.

Authors:  P A Dervan; S F Cahalane; P Kneafsey; A Mynes; K McAllister
Journal:  Histopathology       Date:  1987-02       Impact factor: 5.087

10.  Primary rhabdoid tumour of the brain.

Authors:  S M Jakate; H B Marsden; L Ingram
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988
View more
  15 in total

1.  Primary malignant rhabdoid tumors of the central nervous system: considerations about two cases of adulthood presentation.

Authors:  José Pimentel; Rita Silva; Teresa Pimentel
Journal:  J Neurooncol       Date:  2003-01       Impact factor: 4.130

2.  Malignant rhabdoid tumor in a pregnant adult female: literature review of central nervous system rhabdoid tumors.

Authors:  Michelle L Erickson; Randall Johnson; Serguei I Bannykh; Alain de Lotbiniere; Jung H Kim
Journal:  J Neurooncol       Date:  2005-09       Impact factor: 4.130

Review 3.  Clinicopathologic and cytogenetic analysis of malignant rhabdoid tumor of the central nervous system.

Authors:  R P Hasserjian; R D Folkerth; R M Scott; D E Schofield
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

Review 4.  Continuous remission of newly diagnosed and relapsed central nervous system atypical teratoid/rhabdoid tumor.

Authors:  Mary Ann Zimmerman; Liliana C Goumnerova; Mark Proctor; R Michael Scott; Karen Marcus; Scott L Pomeroy; Christopher D Turner; Susan N Chi; Christine Chordas; Mark W Kieran
Journal:  J Neurooncol       Date:  2005-03       Impact factor: 4.130

5.  Simultaneous presentation of atypical teratoid/rhabdoid tumor in siblings.

Authors:  F Proust; A Laquerriere; B Constantin; M M Ruchoux; J P Vannier; P Fréger
Journal:  J Neurooncol       Date:  1999-05       Impact factor: 4.130

Review 6.  Atypical teratoid/rhabdoid tumors in adult patients: case report and review of the literature.

Authors:  J Lutterbach; J Liegibel; D Koch; A Madlinger; H Frommhold; A Pagenstecher
Journal:  J Neurooncol       Date:  2001-03       Impact factor: 4.130

Review 7.  Atypical teratoid/rhabdoid tumor: the controversy behind radiation therapy.

Authors:  Sarah E Squire; Michael D Chan; Karen J Marcus
Journal:  J Neurooncol       Date:  2006-07-20       Impact factor: 4.130

8.  Primary malignant rhabdoid tumor of the central nervous system--a comprehensive review.

Authors:  Ismail H Tekkök; Aydin Sav
Journal:  J Neurooncol       Date:  2005-07       Impact factor: 4.130

9.  Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood.

Authors:  L B Rorke; R Packer; J Biegel
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

10.  Atypical teratoid/rhabdoid tumor of the central nervous system in an 18-year-old patient.

Authors:  V Samaras; A Stamatelli; E Samaras; I Stergiou; P Konstantopoulou; V Varsos; A R Judkins; J A Biegel; C Barbatis
Journal:  Clin Neuropathol       Date:  2009 Jan-Feb       Impact factor: 1.368

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.